676628-15-2

Basic information

• Product Name: 6-(3-chloro-phenylamino)-N-(2-ethyl-butyl)-4-isopropyl-nicotinamide
• CAS NO: 676628-15-2
• Molecular Weight: 373.926
• Mol File: 676628-15-2.mol

Chemical Properties

• CAS DataBase Reference: 6-(3-chloro-phenylamino)-N-(2-ethyl-butyl)-4-isopropyl-nicotinamide(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(3-chloro-phenylamino)-N-(2-ethyl-butyl)-4-isopropyl-nicotinamide(676628-15-2)
• EPA Substance Registry System: 6-(3-chloro-phenylamino)-N-(2-ethyl-butyl)-4-isopropyl-nicotinamide(676628-15-2)

Safety Data

• Hazardous Substances Data: 676628-15-2(Hazardous Substances Data)

Upstream product

• 676626-86-1 6-(3-chloro-phenylamino)-4-isopropyl-nicotinic acid 
• 617-79-8 2-ethyl-N-butylamine 
• 1101793-27-4 C₁₅H₂₃ClN₂O 
• 108-42-9 3-chloro-aniline 

Relevant articles and documents

Pyridine-3-carboxamides as novel CB2 agonists for analgesia

We describe herein the medicinal chemistry approach which led to the discovery of a novel pyridine-3-carboxamide series of CB2 receptor agonists. The SAR of this new template was evaluated and culminated in the identification of analogue 14a wh

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease